Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, University of Melbourne, Parkville, Australia; Department of Anatomy and Neuroscience, University of Melbourne, Parkville, Australia.
Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, University of Melbourne, Parkville, Australia.
Neurobiol Dis. 2014 Sep;69:248-62. doi: 10.1016/j.nbd.2014.05.004. Epub 2014 May 10.
Huntington's disease (HD) is a neurodegenerative disorder caused by a tandem repeat mutation in the huntingtin gene. Lifestyle factors, such as lack of activity may contribute to the variability in the age of disease onset. Therefore, better understanding of environmental modifiers may uncover potential therapeutic approaches to delay disease onset and progression. Recent data suggest that HD patients and transgenic mouse models show a dysregulated stress response. In this present study, we elevated stress hormone levels through oral corticosterone (CORT) treatment and assessed its impact on the development of motor impairment and cognitive deficits using the R6/1 transgenic mouse model of HD. We found that CORT consumption did not alter rotarod performance of R6/1 HD or wild-type (WT) littermates. However, the onset of hippocampal-dependent Y-maze deficits was accelerated in male R6/1 mice by 5days of CORT treatment, whereas short term memory of WT and female R6/1 mice was unaffected. We then further investigated the male HD susceptibility to CORT by measuring TrkB activation, BDNF and glucocorticoid receptor expression as well as the level of cell proliferation in the hippocampus. CORT treatment increased the levels of phosphorylated TrkB in male R6/1 mice only. There were no effects of CORT on hippocampal BDNF protein or mRNA levels; nor on expression of the glucocorticoid receptors in any group. Hippocampal cell proliferation was decreased in male R6/1 mice and this was further reduced in CORT-drinking male R6/1 mice. Female mice (WT and R6/1) appeared to be protected from the impacts of CORT treatment in all our hippocampal measures. Overall, our data demonstrate that treatment with corticosterone is able to modulate the onset of HD symptomatology. We present the first evidence of a male-specific vulnerability to stress impacting on the development of short-term memory deficits in HD. More generally, we found that female mice were protected from the detrimental effects of CORT treatment on a variety of hippocampus-based measures. Hippocampal plasticity and memory in HD may be more susceptible to the impacts of stress in a sex-dependent manner. We propose clinical investigations of stress as a key environmental modifier of HD symptom onset.
亨廷顿病(HD)是一种神经退行性疾病,由亨廷顿基因中的串联重复突变引起。生活方式因素,如缺乏运动,可能导致疾病发病年龄的差异。因此,更好地了解环境修饰剂可能会发现潜在的治疗方法来延迟疾病的发病和进展。最近的数据表明,HD 患者和转基因小鼠模型表现出应激反应失调。在本研究中,我们通过口服皮质酮(CORT)治疗来提高应激激素水平,并使用 R6/1 转基因 HD 小鼠模型评估其对运动障碍和认知缺陷发展的影响。我们发现 CORT 消耗不会改变 R6/1 HD 或野生型(WT)同窝仔鼠的转棒表现。然而,CORT 处理加速了雄性 R6/1 小鼠海马依赖性 Y 迷宫缺陷的发生,而 WT 和雌性 R6/1 小鼠的短期记忆不受影响。然后,我们通过测量 TrkB 激活、BDNF 和糖皮质激素受体表达以及海马细胞增殖水平,进一步研究了男性 HD 对 CORT 的易感性。CORT 处理仅增加雄性 R6/1 小鼠中磷酸化 TrkB 的水平。CORT 对海马 BDNF 蛋白或 mRNA 水平没有影响;在任何组中也没有糖皮质激素受体的表达。雄性 R6/1 小鼠的海马细胞增殖减少,而在饮用 CORT 的雄性 R6/1 小鼠中则进一步减少。雌性小鼠(WT 和 R6/1)在我们所有的海马测量中似乎都免受 CORT 处理的影响。总体而言,我们的数据表明,皮质酮治疗能够调节 HD 症状的发作。我们首次证明应激对短期记忆缺陷的发展具有雄性特异性易感性。更普遍的是,我们发现雌性小鼠免受 CORT 治疗对各种海马相关测量的不利影响。HD 中的海马可塑性和记忆可能更容易受到应激的影响,具有性别依赖性。我们建议对压力作为 HD 症状发作的关键环境修饰剂进行临床研究。